Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility.

BMC cancer - 25 Jul 2020

Onwuka Justina Ucheojor, Li Dapeng, Liu Yupeng, Huang Hao, Xu Jing, Liu Ying, Zhang Yuanyuan, Zhao Yashuang

Abstract excerpt

BACKGROUND: Differential DNA methylation panel derived from peripheral blood could serve as biomarkers of CRC susceptibility. However, most of the previous studies utilized post-diagnostic blood DNA which may be markers of disease rather than susceptibility. In addition, only a few studies have evaluated the predictive potential of differential DNA methylation in CRC in a prospective cohort and on a genome-wide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to CpG Islands

Share to DNA Methylation

Share to Genetic Markers

Share to Logistic Models

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 32711505
DOI: 10.1186/s12885-020-07194-5
PMCID: PMC7382833

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility.PMID 32711505Read ↗

A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibilitySemantic proximity Read ↗

DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicineSemantic proximity Read ↗

Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancerSemantic proximity Read ↗

Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal CancerSemantic proximity Read ↗

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.Semantic proximity Read ↗

Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal CancerSemantic proximity Read ↗

Clinical Applications of DNA Methylation Biomarkers in Colorectal CancerSemantic proximity Read ↗

DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polypsSemantic proximity Read ↗

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control studySemantic proximity Read ↗

Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution ArraySemantic proximity Read ↗

Genome-wide Analysis of Aberrant DNA Methylation for Identification of Potential Biomarkers in Colorectal Cancer PatientsSemantic proximity Read ↗

DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.